Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NARBADA GEMS vs REMUS PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NARBADA GEMS REMUS PHARMA NARBADA GEMS/
REMUS PHARMA
 
P/E (TTM) x 27.8 - - View Chart
P/BV x 2.6 16.0 16.1% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 NARBADA GEMS   REMUS PHARMA
EQUITY SHARE DATA
    NARBADA GEMS
Mar-24
REMUS PHARMA
Mar-24
NARBADA GEMS/
REMUS PHARMA
5-Yr Chart
Click to enlarge
High Rs1027,895 1.3%   
Low Rs422,950 1.4%   
Sales per share (Unadj.) Rs39.81,445.6 2.8%  
Earnings per share (Unadj.) Rs2.4176.7 1.4%  
Cash flow per share (Unadj.) Rs2.6182.8 1.4%  
Dividends per share (Unadj.) Rs06.00 0.0%  
Avg Dividend yield %00.1 0.0%  
Book value per share (Unadj.) Rs23.5590.9 4.0%  
Shares outstanding (eoy) m21.161.47 1,439.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.83.8 48.2%   
Avg P/E ratio x30.030.7 97.6%  
P/CF ratio (eoy) x28.029.7 94.1%  
Price / Book Value ratio x3.19.2 33.4%  
Dividend payout %03.4 0.0%   
Avg Mkt Cap Rs m1,5267,987 19.1%   
No. of employees `000NANA-   
Total wages/salary Rs m4174 55.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m8432,125 39.7%  
Other income Rs m354 5.6%   
Total revenues Rs m8462,179 38.8%   
Gross profit Rs m87278 31.3%  
Depreciation Rs m49 41.4%   
Interest Rs m185 363.2%   
Profit before tax Rs m69318 21.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1859 30.7%   
Profit after tax Rs m51260 19.6%  
Gross profit margin %10.313.1 78.9%  
Effective tax rate %26.118.4 142.1%   
Net profit margin %6.012.2 49.3%  
BALANCE SHEET DATA
Current assets Rs m7172,097 34.2%   
Current liabilities Rs m2721,495 18.2%   
Net working cap to sales %52.828.4 186.0%  
Current ratio x2.61.4 187.6%  
Inventory Days Days764 10.1%  
Debtors Days Days3201,966 16.3%  
Net fixed assets Rs m54467 11.6%   
Share capital Rs m21215 1,438.2%   
"Free" reserves Rs m285854 33.3%   
Net worth Rs m496869 57.1%   
Long term debt Rs m130 2.9%   
Total assets Rs m7712,564 30.1%  
Interest coverage x4.966.8 7.4%   
Debt to equity ratio x00 5.1%  
Sales to assets ratio x1.10.8 131.9%   
Return on assets %8.910.3 86.0%  
Return on equity %10.229.9 34.3%  
Return on capital %17.436.0 48.3%  
Exports to sales %00-   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA8 0.0%   
Fx inflow Rs m0615 0.0%   
Fx outflow Rs m026 0.0%   
Net fx Rs m0589 0.0%   
CASH FLOW
From Operations Rs m4936 136.7%  
From Investments Rs m-11-89 12.1%  
From Financial Activity Rs m-68244 -27.8%  
Net Cashflow Rs m-29190 -15.4%  

Share Holding

Indian Promoters % 75.0 70.8 105.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.9 -  
FIIs % 0.0 3.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 29.2 85.8%  
Shareholders   7,005 1,753 399.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NARBADA GEMS With:   ADANI ENTERPRISES    MMTC    REDINGTON    SIRCA PAINTS INDIA    VERITAS    


More on STARCHIK SP. vs REMUS PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

STARCHIK SP. vs REMUS PHARMA Share Price Performance

Period STARCHIK SP. REMUS PHARMA
1-Day 1.07% 0.85%
1-Month -12.75% -7.44%
1-Year 16.04% -55.43%
3-Year CAGR 24.28% -9.70%
5-Year CAGR 10.33% -5.94%

* Compound Annual Growth Rate

Here are more details on the STARCHIK SP. share price and the REMUS PHARMA share price.

Moving on to shareholding structures...

The promoters of STARCHIK SP. hold a 75.0% stake in the company. In case of REMUS PHARMA the stake stands at 70.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of STARCHIK SP. and the shareholding pattern of REMUS PHARMA.

Finally, a word on dividends...

In the most recent financial year, STARCHIK SP. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

REMUS PHARMA paid Rs 6.0, and its dividend payout ratio stood at 3.4%.

You may visit here to review the dividend history of STARCHIK SP., and the dividend history of REMUS PHARMA.

For a sector overview, read our retailing sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.